Tag Archives: Genentech

Assessing the Value of Retrospective Studies: Real-World Data, Real-World Applications

by Sarah Ray The value of retrospective studies cannot be overstated. Retrospective studies affect many healthcare sectors, including the pharmaceutical industry and general public health. Applying these studies provides clear advantages at different points of the product life-cycle. During drug development, these studies may help clinical teams propose adaptations or even a companion diagnostic tests […]
Posted in Gene therapy, Global, Guest Blog, healthcare, R&D, Strategy | Also tagged , , , , , , , , , , | Leave a comment

Hepatitis C: Engaging Patients Online

Given the amount of activity in the hepatitis C drug development space – as evidenced in PharmExec’s 2013 Pipeline report – patients are scouring the internet for information on the disease, available treatments, and soon to be available treatments. A new Industry Standard Research report examines the digital cracks consumers encounter when looking for information […]
Posted in Advertising, E-Media, Marketing, multimedia, patient education, social media, Strategy | Also tagged , , , , , , | Leave a comment

New Non-Profit Alliance of Big Pharma Firms

By Amy Ritter. Ten biopharmaceutical companies announced the formation of a nonprofit organization called TransCelerate BioPharma, the mission of which is to accelerate the development of new medicines by identifying and solving common drug development challenges.
Posted in Biotech, Deals, Guest Blog | Also tagged , , , , , , , , , | Leave a comment

Using Social Networks to Increase Sales

Social networks existed long before Mark Zuckerberg came along. What hasn’t existed until recently are the tools, metrics and case studies necessary to understand how physicians influence each other within professional networks, and how these relationships can be used to change prescribing behavior.
Posted in Advertising, leadership, Marketing, Sales, social media, Strategy, Technology | Also tagged , , , , , , , , , | Leave a comment

Genentech Runs Voluntary Corrective Ads for Boniva

Even though Roche-owned Genentech wasn’t required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway.
Posted in Advertising, compliance, Corporate Responsibility, FDA, leadership, Legal, Marketing, Regulatory | Also tagged , , | Leave a comment
  • Categories

  • Meta